Applied DNA Sciences Inc. Regains Nasdaq Listing Compliance, Avoids Delisting Hearing

Reuters
07-07
<a href="https://laohu8.com/S/APDN">Applied DNA Sciences Inc</a>. Regains Nasdaq Listing Compliance, Avoids Delisting Hearing

Applied DNA Sciences Inc., a leader in PCR-based DNA technologies, has announced that it has regained compliance with Nasdaq's continued listing requirements. As of July 2, 2025, the company received a compliance notice from The Nasdaq Stock Market LLC, confirming it meets the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). Consequently, a previously scheduled hearing before the Nasdaq Hearings Panel on July 15, 2025, has been cancelled, and the company's securities will continue to be listed and traded on The Nasdaq Capital Market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applied DNA Sciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1045755) on July 07, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10